NCT06108518View on ClinicalTrials.gov

Clinical Study Evaluating the Effect of Carvedilol in Patients With Active Rheumatoid Arthritis

EARLY_PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

June 1, 2024

Primary Completion Date

October 31, 2024

Study Completion Date

November 30, 2024

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Carvedilol

Treatment group will take carvedilol 12.5mg once a day for 2 days; this is increased to 25 mg once a day or 12.5 mg twice a day for 3 months.

All Listed Sponsors
lead

Tanta University

OTHER

NCT06108518 - Clinical Study Evaluating the Effect of Carvedilol in Patients With Active Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter